Back to Results
First PageMeta Content
Pharmaceuticals policy / Clinical pharmacology / Food and Drug Administration / Therapeutics / United States Public Health Service / Pliva / Pharmaceutical industry / Abbreviated New Drug Application / Extended cycle combined hormonal contraceptive / Pharmaceutical sciences / Pharmacology / Health


Document Date: 2008-04-09 11:52:20

Open Document

File Size: 2,49 MB

Share Result on Facebook

City

Montvale / Zagreb / /

Company

Duramed Pharmaceuticals / Barr Laboratories / Novartis / OrthoMcNeil-Janssen Pharmaceuticals Inc. / Amgen / Common Sense Ltd. / Sandoz / Apotex Inc. / Watson Pharmaceuticals / O.R.C.A. / Warner Chilcott / Wyeth Laboratories / Paladin Labs Inc. / Par Pharmaceutical Companies Inc. / Bayer Schering Pharma AG / Merck & Co. Inc. / PLIVA d.d. / Pfizer / PLAN B TM / Valeant Pharmaceuticals North America / Barr Pharmaceuticals / /

Continent

Europe / /

Country

Canada / Germany / Croatia / Italy / Poland / Russia / United States / Spain / /

Currency

USD / /

Event

Business Partnership / FDA Phase / M&A / Accounting Change / Reorganization / Funding / /

Facility

U.S. District Court / Corporate Headquarters / Biologics Plant / /

IndustryTerm

dozen products / generic biologics products / generic product / injectable products / insomnia treatment / oral contraceptive product / finance team / oral product / female healthcare therapeutic category / contraceptive product / generic pharmaceutical / internal product / osteoporosis treatment / manufacturing / generic injectable products / long-term proprietary products / acquired specialty pharmaceutical / distinctive products / treatment for schizophrenia and Bipolar Disorder / drug delivery technologies / manufacturing operations / commodity products / pharmaceutical products / generic products / rectal gel epilepsy products / /

MedicalCondition

ADHD / schizophrenia / rectal gel epilepsy / Attention Deficit Hyperactivity Disorder / 70mg osteoporosis / insomnia / bronchospasm / Bipolar Disorder / /

MedicalTreatment

oral contraceptives / /

Organization

Patent and Trademark Office / Division of OrthoMcNeil-Janssen Pharmaceuticals / U.S. Department of Defense / U.S. District Court for the District of New Jersey / FDA / Institutional Sales Force / European Union / Strengthened Proprietary Sales Force / Congress / Therapeutic Products Directorate / U.S. Food and Drug Administration / North American Menopause Society / /

Person

Bruce L. Downey / /

Position

Chairman and CEO / Chairman / sales Chief Executive Officer / /

Product

Fosamax / Neupogen / Estrostep / ENJUVIA / Ambien CR / Diazepam / Abilify / Yasmin / TRI-LEGEST Fe / Ritalin LA / SEASONIQUE / SEASONALE / Wyeth Laboratories’ Min-OvralTM Tablets / Zithromax / Xopenex / Azithromycin / Diastat / ADDERALL / PORTIA / Thalomid / TM Estrostep® Fe / BIJUVA™ / Adenovirus vaccine / New Drug / Settled Diazepam Rectal Gel / SEASONALE® Patent Re / Company / PORTIA® / /

ProvinceOrState

New Jersey / /

Region

Central Europe / Eastern Europe / /

Technology

drug delivery technologies / /

SocialTag